Endocrine and metabolic disorders in young adult survivors of childhood acute lymphoblastic leukaemia (ALL) or non‐Hodgkin lymphoma (NHL)

Clinical Endocrinology - Tập 69 Số 5 - Trang 819-827 - 2008
Mélanie Steffens1, Véronique Beauloye2, Bénédicte Brichard3, Annie Robert4, Orsalia Alexopoulou1, Ch. Vermylen3, Dominique Maiter1
1Divisions of Endocrinology and Nutrition,
2Pediatric Endocrinology
3Pediatric Hematology and Oncology,
4Unit of Epidemiology and Biostatistics, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium

Tóm tắt

SummaryBackground  Treatments of acute lymphoblastic leukaemia (ALL) and non‐Hodgkin lymphoma (NHL), involving various combinations of chemotherapy (chemo), cranial irradiation (CI) and/or bone marrow transplantation after total body irradiation (BMT/TBI), are often successful but may have several long‐term harmful effects.Objective  To evaluate late endocrine and metabolic complications in adult survivors of childhood ALL and NHL, in relation with the different therapeutic schemes received.Design  Endocrine and metabolic parameters were determined in 94 patients (48 men, mean age: 24 ± 5 years) with a former childhood ALL (n = 78) or NHL (n = 16) and subgrouped according to their previous treatment: chemo only (group I; n = 44), chemo + CI (group II; n = 32) and chemo + BMT/TBI (group III; n = 18).Results  Severe GH deficiency (peak < 3·0 ng/ml after glucagon) was observed in 22% and 50% of patients of groups II and III, respectively, while hypothyroidism was mainly observed in group III (56%). Moreover, 83% of men developed hypogonadism after BMT/TBI, compared to 17% and 8% in groups I and II, respectively (P < 0·05), and all grafted women had ovarian failure, in contrast with other female patients in whom menarche had occurred spontaneously. Patients with BMT/TBI had also an adverse metabolic profile, with insulin resistance in 83% and dyslipidaemia in 61%.Conclusions  This study reveals a high prevalence of endocrine and metabolic disorders in young adult survivors of childhood ALL or NHL, this frequency mainly depending on the treatment received. Treatment with BMT/TBI is the most detrimental and many of these patients will develop GHD, hypothyroidism, hypogonadism, insulin resistance and dyslipidaemia.

Từ khóa


Tài liệu tham khảo

10.1056/NEJMra052603

10.1056/NEJMsa060185

10.1046/j.1365-2265.1998.00438.x

10.1046/j.1365-2265.2001.01292.x

Tucker M.A., 1991, Therapeutic radiation at a young age is linked to secondary thyroid cancer. The Late Effects Study Group, Cancer Research, 51, 2885

10.1159/000067835

10.1200/JCO.1993.11.2.239

10.1210/jc.2004-0126

10.1097/00043426-200110000-00007

10.1016/S0140-6736(00)02717-3

10.1136/bmj.320.7244.1240

10.1016/S0140-6736(05)67402-8

10.1002/(SICI)1097-0258(19980228)17:4<407::AID-SIM742>3.0.CO;2-L

10.1136/adc.51.3.170

10.1530/EJE-07-0631

10.1159/000071871

10.1007/s001250051215

10.1159/000067834

Littley M.D., 1989, Hypopituitarism following external radiotherapy for pituitary tumours in adults, Quarterly Medical Review, 70, 145

Darzy K.H., 2005, Hypopituitarism after cranial irradiation, Journal of Endocrinological Investigation, 28, 78

10.1111/j.1365-2265.1985.tb00187.x

10.1002/pbc.20485

10.1038/sj.bmt.1704945

10.1016/j.arcped.2004.07.017

10.1210/jc.2004-0836

10.1007/BF03346906

Pasqualini T., 1991, Subtle primary hypothyroidism in patients treated for acute lymphoblastic leukemia, Acta Endocrinologia Copenhagen, 124, 375

10.1002/cncr.11362

10.1016/S0022-3468(03)00563-3

10.1097/00062752-200007000-00004

10.1093/humrep/deg016

10.1111/j.1471-0528.1999.tb08180.x

10.1038/sj.bmt.1701075

10.1007/s004310050006

10.1034/j.1399-3046.1999.00006.x

10.1093/humrep/16.9.1838

10.1210/jc.2003-030352

10.1016/0002-9378(92)91335-8

10.1002/mpo.2950210505

10.1136/adc.62.11.1107

10.1111/j.1365-2605.1991.tb01098.x

10.1677/joe.0.1200161

10.2337/diabetes.47.10.1643

10.1186/1471-2296-7-43

10.1136/bmj.313.7056.559d

10.1111/j.1365-2265.2005.02194.x

10.1530/eje.1.01931

Thông tin
Thông tin xuất bản

Clinical Endocrinology

Tập 69 Số 5

819-827

Thông tin tác giả